Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Hi-Tech Pharmacal Co., Inc.
WARNING LETTER
•Hi-Tech Pharmacal Co., Inc.•December 3, 2009

Hi-Tech Pharmacal Co., Inc. – FDA Warning Letter, Dec 3, 2009

Record Details

An FDA inspection of Hi-Tech Pharmacal Co., Inc. from October 21 to December 3, 2009, revealed significant violations of Current Good Manufacturing Practice (CGMP) regulations (21 CFR Parts 210 and 211), rendering their drug products adulterated. Additionally, the firm manufactures and distributes an unapproved new drug, Paregoric Liquid, USP, violating sections 301(d) and 505(a) of the Federal Food, Drug, and Cosmetic Act, and misbranding it under section 502(f)(1).

Key CGMP violations include: 1. Failure to establish adequate laboratory control mechanisms, exemplified by releasing Prednisolone API (Lot 26910) despite out-of-specification (OOS) results for impurities and unsupported OOS investigation conclusions. 2. Lack of scientifically sound specifications and test procedures, such as failing to perform residual solvent testing for certain drug products, not drying or determining water content of in-house reference standards, and not confirming normality factors of commercially prepared volumetric solutions. 3. Failure to record and justify deviations from written specifications, like incorrect expiration dating for Riboflavin 5' Phosphate Sodium reference standard. 4. Inadequate validation of test methods for assay analysis of various vitamin drops and Urea Cream 40%, lacking characteristics like accuracy, robustness, and specificity, and insufficient chromatographic data.

Company
Hi-Tech Pharmacal Co., Inc.
Inspection date
December 3, 2009
Product type
Drugs
Office
New York District Office
Person
  • Ronald M. Pace (Program Director)
View Company Profile

ID · 30a3d4dd-c2bb-4118-82a0-91b64f2dd52e

Violation Codes10
21 U.S.C. 321(g)21 CFR 21021 CFR 21121 CFR 201.11521 CFR 211.160(b)(1)21 CFR 211.160(b)21 CFR 211.160(a)21 CFR 211.165(e)21 CFR 211.10021 CFR 211.165(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hi-Tech Pharmacal Co., Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.